Complications and Patient-Reported Outcomes in Male-to-Female Vaginoplasty-Where We Are Today: A Systematic Review and Meta-Analysis
Overview
Authors
Affiliations
Introduction: There is an increased need for evidence-based practices in male-to-female (MtF) transgender vaginoplasty. Although there are a multitude of surgical techniques, there is a paucity of data comparing these procedures. A systematic review of retrospective studies on the outcomes of MtF vaginoplasty was conducted to minimize surgical complications and improve patient outcomes for transgender patients.
Methods: Applying the Preferred Reporting Items for Systematic Review and Meta-Analysis, a comprehensive search of several databases from 1985 to November 7, 2017, was conducted. The databases included PubMed, Ovid MEDLINE Epub Ahead of Print, Ovid Medline In-Process & Other Non-Indexed Citations, Ovid MEDLINE, Ovid EMBASE, Ovid Cochrane Central Register of Controlled Trials, and Web of Science. The resulting publications were screened, and those that met our specified inclusion/exclusion criteria were analyzed. The DerSimonian and Laird random-effects model was used to pool complications and patient-reported outcomes.
Results: A total of 471 articles were initially identified, of which 46 met our eligibility criteria. A total of 3716 cases were analyzed. Overall incidence of complications included the following: 2% (1%-6%) fistula, 14% (10%-18%) stenosis and strictures, and 1% (0%-6%) tissue necrosis, and 4% (2%-10%) prolapse (upper and lower limits of the 95% confidence interval). Patient-reported outcomes included a satisfaction rate of 93% (79%-100%) with overall results, 87% (75%-96%) with functional outcomes, and 90% (79%-98%) with esthetic outcomes. Ability to have orgasm was reported in 70% (54%-84%) of patients. The regret rate was 1% (0%-3%). The length of the vaginal cavity was 12.5 cm (6.3-4.4 cm).
Conclusions: Multiple surgical techniques have demonstrated safe and reliable means of MtF vaginoplasty with low overall complication rates and with a significant improvement in the patient's quality of life. Studies using different techniques in a similar population and standardized patient-reported outcomes are required to further analyze outcomes among the different procedures and to establish best-practice guidelines.
Mijuskovic B, Niggli S, Bausch K, Nunez D, Schaefer D, Feicke A Int J Transgend Health. 2025; 26(1):134-144.
PMID: 39981270 PMC: 11837940. DOI: 10.1080/26895269.2024.2305201.
A sterilization method for human decellularized vaginal matrices.
Sueters J, de Boer L, Groenman F, Huirne J, Smit T, Zaat S Sci Rep. 2024; 14(1):31728.
PMID: 39738284 PMC: 11685901. DOI: 10.1038/s41598-024-82409-4.
The microbiome of the neovagina: a systematic review and comparison of surgical techniques.
Stoehr J, Moss C, A H Int J Transgend Health. 2024; 25(4):623-633.
PMID: 39465075 PMC: 11500519. DOI: 10.1080/26895269.2023.2237014.
Hypergranulation management following penile inversion vaginoplasty.
Potter E, Shah G, Krakowsky Y, Armstrong K, Remondini T, Anashara N Can Fam Physician. 2024; 70(7-8):456-461.
PMID: 39122430 PMC: 11328711. DOI: 10.46747/cfp.700708456.
Hegde S, Carroll E, Doo F, Drzewiecki B, Jensen K, Sertic M Abdom Radiol (NY). 2024; 49(8):2812-2832.
PMID: 38832942 DOI: 10.1007/s00261-024-04385-7.